UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Occurrence of 3-MCPD fatty acid esters in human breast milk

Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment, 2008-06, Vol.25 (6), p.669-676

2008

Link zum Volltext

Verfügbarkeit prüfen

Impact of the growth hormone replacement on bone status in growth hormone deficient adults

Growth hormone & IGF research, 2014-02, Vol.24 (1), p.22-28

2014

Link zum Volltext

Verfügbarkeit prüfen

3-Chloropropane-1,2-diol Fatty Acid Esters in Potato Products

Czech Journal of Food Sciences, 2009-01, Vol.27 (Special Issue 1), p.S421-S424

2009

Link zum Volltext

Verfügbarkeit prüfen

The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2015-02, Vol.9 (2), p.107-124

2015

Link zum Volltext

Verfügbarkeit prüfen

Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety

Gut, 2016-08, Vol.65 (8), p.1261-1268

2016

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity negatively influences the outcome of adalimumab treatment in Crohn’s disease

Alimentary pharmacology & therapeutics, 2008-11, Vol.28 (9), p.1122-1126

2008

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Bread Lipids for 3-MCPD Esters

Czech Journal of Food Sciences, 2009-01, Vol.27 (Special Issue 1), p.S417-S420

2009

Link zum Volltext

Verfügbarkeit prüfen

Fatty acid esters of 3-chloropropane-1,2-diol in edible oils

Food additives and contaminants, 2006-12, Vol.23 (12), p.1290-1298

2006

Link zum Volltext

Verfügbarkeit prüfen

High intra‐uterine exposure to infliximab following maternal anti‐TNF treatment during pregnancy

Alimentary pharmacology & therapeutics, 2011-05, Vol.33 (9), p.1053-1058

2011

Link zum Volltext

Verfügbarkeit prüfen

Predictors of dose escalation of adalimumab in a prospective cohort of Crohn's disease patients

Alimentary pharmacology & therapeutics, 2012-02, Vol.35 (3), p.335-341

2012

Link zum Volltext

Verfügbarkeit prüfen

Adalimumab in Crohn's disease patients: pharmacokinetics in the first 6 months of treatment

Alimentary pharmacology & therapeutics, 2014-11, Vol.40 (10), p.1202-1208

2014

Link zum Volltext

Verfügbarkeit prüfen

A Prospective Study of the Safety of Lower Gastrointestinal Endoscopy During Pregnancy in Patients with Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2015-07, Vol.9 (7), p.519-524

2015

Link zum Volltext

Verfügbarkeit prüfen

P528 Effectiveness, Safety and Incremental Costs of Proactive Therapeutic Drug Monitoring of Infliximab in a Prospective Cohort of Inflammatory Bowel Disease Patients

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i657-i658

2023

Link zum Volltext

Verfügbarkeit prüfen

3-Chloropropane-1,2-diol fatty acid esters in potato products

Czech Journal of Food Sciences, 2011-01, Vol.29 (4), p.411-419

2011

Link zum Volltext

Verfügbarkeit prüfen

Formation of acylglycerol chloro derivatives in vegetable oils and mitigation strategy

Czech Journal of Food Sciences, 2011-01, Vol.29 (4), p.448-456

2011

Link zum Volltext

Verfügbarkeit prüfen

Recommendations of the Slovak IBD Working Group on SGS for the Treatment of Biosimilar Anti-TNF Biologics in Adult and Pediatric Patients

Gastroenterologie a hepatologie, 2020-04 (In press), p.130-134

2020

Link zum Volltext

Verfügbarkeit prüfen

P392 Behaviour of Childhood-onset Inflammatory Bowel Disease through Adulthood

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i822-i822

2024

Link zum Volltext

Verfügbarkeit prüfen

P461 Vedolizumab Dose Escalation in a Real-World Cohort of IBD Patients

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S454-S454

2021

Link zum Volltext

Verfügbarkeit prüfen

Azathioprine treatment during lactation

Alimentary pharmacology & therapeutics, 2009-07, Vol.30 (1), p.90-91

2009

Link zum Volltext

Verfügbarkeit prüfen

P655 MadCAM1 Negativity of Lamina Propria Endothelial Cells is Associated with Non-Response to Vedolizumab in Inflammatory Bowel Disease Patients

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i783-i784

2023

Link zum Volltext

Verfügbarkeit prüfen

P512 Vedolizumab is effective in the prevention and treatment of postoperative recurrence in patients with Crohn′s disease

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i470-i470

2022

Link zum Volltext

Verfügbarkeit prüfen

P470 Ustekinumab Trough Levels are not Associated with Clinical Response in Inflammatory Bowel Disease Patients

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S460-S461

2021

Link zum Volltext

Verfügbarkeit prüfen

High therapy adherence but substantial limitations to daily activities amongst members of the Dutch inflammatory bowel disease patients' organization: a patient empowerment study

Alimentary pharmacology & therapeutics, 2009-10, Vol.30 (8), p.864-872

2009

Link zum Volltext

Verfügbarkeit prüfen

P303 Local Application of Autologous Platelet-rich Plasma leads to Sustained Healing of Crohn’s Perianal Fistulae – One Year follow-up Results from a Single Center Pilot Study

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S331-S332

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(66)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(23)
Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Female
(16)
Adult
(13)
Gastroenterology & Hepatology
(13)
Male
(8)
Pregnancy
(8)
Biological And Medical Sciences
(7)
Food Science & Technology
(7)
3-Chloropropane-1,2-Diol
(6)
Crohn Disease - Drug Therapy
(6)
Middle Aged
(6)
Pharmacology & Pharmacy
(6)
Gastroenterology. Liver. Pancreas. Abdomen
(5)
Inflammatory Bowel Disease
(5)
Medical Sciences
(5)
Young Adult
(5)
Adolescent
(4)
Aged
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Occurrence of 3-MCPD fatty acid esters in human breast milk

Impact of the growth hormone replacement on bone status in growth hormone deficient adults

3-Chloropropane-1,2-diol Fatty Acid Esters in Potato Products

The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease

Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety

Immunogenicity negatively influences the outcome of adalimumab treatment in Crohn’s disease

Analysis of Bread Lipids for 3-MCPD Esters

Fatty acid esters of 3-chloropropane-1,2-diol in edible oils

High intra‐uterine exposure to infliximab following maternal anti‐TNF treatment during pregnancy

Predictors of dose escalation of adalimumab in a prospective cohort of Crohn's disease patients

Adalimumab in Crohn's disease patients: pharmacokinetics in the first 6 months of treatment

A Prospective Study of the Safety of Lower Gastrointestinal Endoscopy During Pregnancy in Patients with Inflammatory Bowel Disease

P528 Effectiveness, Safety and Incremental Costs of Proactive Therapeutic Drug Monitoring of Infliximab in a Prospective Cohort of Inflammatory Bowel Disease Patients

3-Chloropropane-1,2-diol fatty acid esters in potato products

Formation of acylglycerol chloro derivatives in vegetable oils and mitigation strategy

Recommendations of the Slovak IBD Working Group on SGS for the Treatment of Biosimilar Anti-TNF Biologics in Adult and Pediatric Patients

P392 Behaviour of Childhood-onset Inflammatory Bowel Disease through Adulthood

P461 Vedolizumab Dose Escalation in a Real-World Cohort of IBD Patients

Azathioprine treatment during lactation

P655 MadCAM1 Negativity of Lamina Propria Endothelial Cells is Associated with Non-Response to Vedolizumab in Inflammatory Bowel Disease Patients

European Crohn’s and Colitis Guidelines on Sexuality, Fertility, Pregnancy, and Lactation

P512 Vedolizumab is effective in the prevention and treatment of postoperative recurrence in patients with Crohn′s disease

P470 Ustekinumab Trough Levels are not Associated with Clinical Response in Inflammatory Bowel Disease Patients

High therapy adherence but substantial limitations to daily activities amongst members of the Dutch inflammatory bowel disease patients' organization: a patient empowerment study

P303 Local Application of Autologous Platelet-rich Plasma leads to Sustained Healing of Crohn’s Perianal Fistulae – One Year follow-up Results from a Single Center Pilot Study

Suchergebnisse filtern